{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:39:00Z","timestamp":1791873540062,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03828-x","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T13:01:46Z","timestamp":1716037306000},"page":"1178-1192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Metformin-induced changes of the gut microbiota in patients with type 2 diabetes mellitus: results from a prospective cohort study"],"prefix":"10.1007","volume":"85","author":[{"given":"Yuting","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"issue":"10397","key":"3828_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"Collaborators GBDD","year":"2023","unstructured":"Collaborators GBDD, Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402(10397), 203\u2013234 (2023). https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6","journal-title":"Lancet"},{"issue":"17","key":"3828_CR2","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"U. Galicia-Garcia, A. Benito-Vicente, S. Jebari, A. Larrea-Sebal, H. Siddiqi, K.B. Uribe et al. Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci. 21(17), 6275 (2020). https:\/\/doi.org\/10.3390\/ijms21176275","journal-title":"Int. J. Mol. Sci."},{"key":"3828_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"H. Sun, P. Saeedi, S. Karuranga, M. Pinkepank, K. Ogurtsova, B.B. Duncan et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022). https:\/\/doi.org\/10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"9","key":"3828_CR4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","volume":"63","author":"H Tilg","year":"2014","unstructured":"H. Tilg, A.R. Moschen, Microbiota and diabetes: an evolving relationship. Gut 63(9), 1513\u20131521 (2014). https:\/\/doi.org\/10.1136\/gutjnl-2014-306928","journal-title":"Gut"},{"issue":"1","key":"3828_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-021-00446-0","volume":"13","author":"AL Cunningham","year":"2021","unstructured":"A.L. Cunningham, J.W. Stephens, D.A. Harris, Gut microbiota influence in type 2 diabetes mellitus (T2DM). Gut. Pathog. 13(1), 50 (2021). https:\/\/doi.org\/10.1186\/s13099-021-00446-0","journal-title":"Gut. Pathog."},{"key":"3828_CR6","doi-asserted-by":"publisher","unstructured":"R. Li, F. Shokri, A.L. Rincon, F. Rivadeneira, C. Medina-Gomez, F. Ahmadizar, Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. Genes. 14(8) (2023) https:\/\/doi.org\/10.3390\/genes14081572","DOI":"10.3390\/genes14081572"},{"issue":"8","key":"3828_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"M. Foretz, B. Guigas, B. Viollet, Metformin: update on mechanisms of action and repurposing potential. Nat. Rev. Endocrinol. 19(8), 460\u2013476 (2023). https:\/\/doi.org\/10.1038\/s41574-023-00833-4","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"3828_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","volume":"59","author":"LJ McCreight","year":"2016","unstructured":"L.J. McCreight, C.J. Bailey, E.R. Pearson, Metformin and the gastrointestinal tract. Diabetologia 59(3), 426\u2013435 (2016). https:\/\/doi.org\/10.1007\/s00125-015-3844-9","journal-title":"Diabetologia"},{"issue":"8","key":"3828_CR9","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","volume":"51","author":"CJ Bailey","year":"2008","unstructured":"C.J. Bailey, C. Wilcock, J.H. Scarpello, Metformin and the intestine. Diabetologia 51(8), 1552\u20131553 (2008). https:\/\/doi.org\/10.1007\/s00125-008-1053-5","journal-title":"Diabetologia"},{"issue":"1","key":"3828_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1185\/03007998409109558","volume":"9","author":"E Bonora","year":"1984","unstructured":"E. Bonora, M. Cigolini, O. Bosello, C. Zancanaro, L. Capretti, I. Zavaroni et al. Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects. Curr. Med. Res. Opin. 9(1), 47\u201351 (1984). https:\/\/doi.org\/10.1185\/03007998409109558","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"3828_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc15-0488","volume":"39","author":"JB Buse","year":"2016","unstructured":"J.B. Buse, R.A. DeFronzo, J. Rosenstock, T. Kim, C. Burns, S. Skare et al. The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies. Diabetes Care 39(2), 198\u2013205 (2016). https:\/\/doi.org\/10.2337\/dc15-0488","journal-title":"Diabetes Care"},{"issue":"5","key":"3828_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"NR Shin","year":"2014","unstructured":"N.R. Shin, J.C. Lee, H.Y. Lee, M.S. Kim, T.W. Whon, M.S. Lee et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63(5), 727\u2013735 (2014). https:\/\/doi.org\/10.1136\/gutjnl-2012-303839","journal-title":"Gut"},{"key":"3828_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101805","volume":"77","author":"P Pavlo","year":"2023","unstructured":"P. Pavlo, I. Kamyshna, A. Kamyshnyi, Effects of metformin on the gut microbiota: A systematic review. Mol. Metab. 77, 101805 (2023). https:\/\/doi.org\/10.1016\/j.molmet.2023.101805","journal-title":"Mol. Metab."},{"issue":"7","key":"3828_CR14","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/dc20-2257","volume":"44","author":"NT Mueller","year":"2021","unstructured":"N.T. Mueller, M.K. Differding, M. Zhang, N.M. Maruthur, S.P. Juraschek, E.R. Miller 3rd et al. Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial. Diabetes Care 44(7), 1462\u20131471 (2021). https:\/\/doi.org\/10.2337\/dc20-2257","journal-title":"Diabetes Care"},{"issue":"1","key":"3828_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"J de la Cuesta-Zuluaga","year":"2017","unstructured":"J. de la Cuesta-Zuluaga, N.T. Mueller, V. Corrales-Agudelo, E.P. Velasquez-Mejia, J.A. Carmona, J.M. Abad et al. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. Diabetes Care 40(1), 54\u201362 (2017). https:\/\/doi.org\/10.2337\/dc16-1324","journal-title":"Diabetes Care"},{"issue":"7581","key":"3828_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"K Forslund","year":"2015","unstructured":"K. Forslund, F. Hildebrand, T. Nielsen, G. Falony, E. Le Chatelier, S. Sunagawa et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528(7581), 262\u2013266 (2015). https:\/\/doi.org\/10.1038\/nature15766","journal-title":"Nature"},{"issue":"3","key":"3828_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12020-019-02041-5","volume":"66","author":"F Zhang","year":"2019","unstructured":"F. Zhang, M. Wang, J. Yang, Q. Xu, C. Liang, B. Chen et al. Response of gut microbiota in type 2 diabetes to hypoglycemic agents. Endocrine 66(3), 485\u2013493 (2019). https:\/\/doi.org\/10.1007\/s12020-019-02041-5","journal-title":"Endocrine"},{"issue":"10","key":"3828_CR18","doi-asserted-by":"publisher","first-page":"e0241338","DOI":"10.1371\/journal.pone.0241338","volume":"15","author":"I Elbere","year":"2020","unstructured":"I. Elbere, I. Silamikelis, I.I. Dindune, I. Kalnina, M. Ustinova, L. Zaharenko et al. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients. PLoS One 15(10), e0241338 (2020). https:\/\/doi.org\/10.1371\/journal.pone.0241338","journal-title":"PLoS One"},{"issue":"12","key":"3828_CR19","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"L. Sun, C. Xie, G. Wang, Y. Wu, Q. Wu, X. Wang et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat. Med. 24(12), 1919\u20131929 (2018). https:\/\/doi.org\/10.1038\/s41591-018-0222-4","journal-title":"Nat. Med."},{"issue":"9","key":"3828_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/life10090195","volume":"10","author":"H Nakajima","year":"2020","unstructured":"H. Nakajima, F. Takewaki, Y. Hashimoto, S. Kajiyama, S. Majima, H. Okada et al. The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study. Life 10(9), 195 (2020). https:\/\/doi.org\/10.3390\/life10090195","journal-title":"Life"},{"issue":"7","key":"3828_CR21","doi-asserted-by":"publisher","first-page":"e100778","DOI":"10.1371\/journal.pone.0100778","volume":"9","author":"A Napolitano","year":"2014","unstructured":"A. Napolitano, S. Miller, A.W. Nicholls, D. Baker, S. Van Horn, E. Thomas et al. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One 9(7), e100778 (2014). https:\/\/doi.org\/10.1371\/journal.pone.0100778","journal-title":"PLoS One"},{"issue":"21","key":"3828_CR22","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","volume":"27","author":"T Magoc","year":"2011","unstructured":"T. Magoc, S.L. Salzberg, FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27(21), 2957\u20132963 (2011). https:\/\/doi.org\/10.1093\/bioinformatics\/btr507","journal-title":"Bioinformatics"},{"key":"3828_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fendo.2017.00301","volume":"8","author":"CA Dennison","year":"2017","unstructured":"C.A. Dennison, A.J. Eslinger, R.A. Reimer, Preconception Prebiotic and Sitagliptin Treatment in Obese Rats Affects Pregnancy Outcomes and Offspring Microbiota, Adiposity, and Glycemia. Front. Endocrinol. 8, 301 (2017). https:\/\/doi.org\/10.3389\/fendo.2017.00301","journal-title":"Front. Endocrinol."},{"issue":"6","key":"3828_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"N. Segata, J. Izard, L. Waldron, D. Gevers, L. Miropolsky, W.S. Garrett et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12(6), R60 (2011). https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60","journal-title":"Genome Biol."},{"issue":"12","key":"3828_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"M.I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15(12), 550 (2014). https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol."},{"issue":"2","key":"3828_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1109\/tpami.1986.4767778","volume":"8","author":"RL Cannon","year":"1986","unstructured":"R.L. Cannon, J.V. Dave, J.C. Bezdek, Efficient Implementation of the Fuzzy c-Means Clustering Algorithms. IEEE Trans. Pattern Anal. Mach. Intell. 8(2), 248\u2013255 (1986). https:\/\/doi.org\/10.1109\/tpami.1986.4767778","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"issue":"6","key":"3828_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"G.M. Douglas, V.J. Maffei, J.R. Zaneveld, S.N. Yurgel, J.R. Brown, C.M. Taylor et al. PICRUSt2 for prediction of metagenome functions. Nat. Biotechnol. 38(6), 685\u2013688 (2020). https:\/\/doi.org\/10.1038\/s41587-020-0548-6","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"3828_CR28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"A. Koh, F. De Vadder, P. Kovatcheva-Datchary, F. Backhed, From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell 165(6), 1332\u20131345 (2016). https:\/\/doi.org\/10.1016\/j.cell.2016.05.041","journal-title":"Cell"},{"key":"3828_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.copbio.2020.10.005","volume":"66","author":"SY Park","year":"2020","unstructured":"S.Y. Park, A. Ufondu, K. Lee, A. Jayaraman, Emerging computational tools and models for studying gut microbiota composition and function. Curr. Opin. Biotechnol. 66, 301\u2013311 (2020). https:\/\/doi.org\/10.1016\/j.copbio.2020.10.005","journal-title":"Curr. Opin. Biotechnol."},{"issue":"9","key":"3828_CR30","doi-asserted-by":"publisher","first-page":"e0204317","DOI":"10.1371\/journal.pone.0204317","volume":"13","author":"I Elbere","year":"2018","unstructured":"I. Elbere, I. Kalnina, I. Silamikelis, I. Konrade, L. Zaharenko, K. Sekace et al. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers. PLoS One 13(9), e0204317 (2018). https:\/\/doi.org\/10.1371\/journal.pone.0204317","journal-title":"PLoS One"},{"key":"3828_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3876764","volume":"2016","author":"S Mrozinska","year":"2016","unstructured":"S. Mrozinska, P. Radkowski, T. Gosiewski, M. Szopa, M. Bulanda, A.H. Ludwig-Galezowska et al. Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes Mellitus. J. Diabetes Res. 2016, 3876764 (2016). https:\/\/doi.org\/10.1155\/2016\/3876764","journal-title":"J. Diabetes Res."},{"issue":"1","key":"3828_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/microorganisms8010094","volume":"8","author":"A Chavez-Carbajal","year":"2020","unstructured":"A. Chavez-Carbajal, M.L. Pizano-Zarate, F. Hernandez-Quiroz, G.F. Ortiz-Luna, R.M. Morales-Hernandez, A. De Sales-Millan et al. Characterization of the Gut Microbiota of Individuals at Different T2D Stages Reveals a Complex Relationship with the Host. Microorganisms 8(1), 94 (2020). https:\/\/doi.org\/10.3390\/microorganisms8010094","journal-title":"Microorganisms"},{"key":"3828_CR33","doi-asserted-by":"publisher","unstructured":"E. Sepp, H. Kolk, K. Loivukene, M. Mikelsaar Higher blood glucose level associated with body mass index and gut microbiota in elderly people. Microb. Ecol. Health Dis. 25 (2014). https:\/\/doi.org\/10.3402\/mehd.v25.22857","DOI":"10.3402\/mehd.v25.22857"},{"issue":"2","key":"3828_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcjd.2019.05.008","volume":"44","author":"PM Ryan","year":"2020","unstructured":"P.M. Ryan, E. Patterson, I. Carafa, R. Mandal, D.S. Wishart, T.G. Dinan et al. Metformin and Dipeptidyl Peptidase-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice. Can. J. Diabetes 44(2), 146\u201355.e2 (2020). https:\/\/doi.org\/10.1016\/j.jcjd.2019.05.008","journal-title":"Can. J. Diabetes"},{"issue":"2","key":"3828_CR35","doi-asserted-by":"publisher","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","volume":"5","author":"N Larsen","year":"2010","unstructured":"N. Larsen, F.K. Vogensen, F.W. van den Berg, D.S. Nielsen, A.S. Andreasen, B.K. Pedersen et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2), e9085 (2010). https:\/\/doi.org\/10.1371\/journal.pone.0009085","journal-title":"PLoS One"},{"issue":"3","key":"3828_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/EJE-18-0826","volume":"180","author":"HS Ejtahed","year":"2019","unstructured":"H.S. Ejtahed, R.Y. Tito, S.D. Siadat, S. Hasani-Ranjbar, Z. Hoseini-Tavassol, L. Rymenans et al. Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial. Eur. J. Endocrinol. 180(3), 165\u2013176 (2019). https:\/\/doi.org\/10.1530\/EJE-18-0826","journal-title":"Eur. J. Endocrinol."},{"key":"3828_CR37","doi-asserted-by":"publisher","unstructured":"X. Niu, P. Lu, L. Huang, Y. Sun, M. Jin, J. Liu, et al. The effect of metformin combined with liraglutide on gut microbiota of Chinese patients with type 2 diabetes. Int. Microbiol. (2023). https:\/\/doi.org\/10.1007\/s10123-023-00380-y","DOI":"10.1007\/s10123-023-00380-y"},{"issue":"9","key":"3828_CR38","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41430-020-0607-6","volume":"74","author":"L Crovesy","year":"2020","unstructured":"L. Crovesy, D. Masterson, E.L. Rosado, Profile of the gut microbiota of adults with obesity: a systematic review. Eur. J. Clin. Nutr. 74(9), 1251\u20131262 (2020). https:\/\/doi.org\/10.1038\/s41430-020-0607-6","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"3828_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4291\/wjgp.v6.i4.110","volume":"6","author":"CK Chakraborti","year":"2015","unstructured":"C.K. Chakraborti, New-found link between microbiota and obesity. World J. Gastrointest. Pathophysiol. 6(4), 110\u2013119 (2015). https:\/\/doi.org\/10.4291\/wjgp.v6.i4.110","journal-title":"World J. Gastrointest. Pathophysiol."},{"issue":"1","key":"3828_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1880221","volume":"13","author":"T Tavella","year":"2021","unstructured":"T. Tavella, S. Rampelli, G. Guidarelli, A. Bazzocchi, C. Gasperini, E. Pujos-Guillot et al. Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly. Gut Microbes 13(1), 1\u201319 (2021). https:\/\/doi.org\/10.1080\/19490976.2021.1880221","journal-title":"Gut Microbes"},{"issue":"2","key":"3828_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.chom.2014.12.009","volume":"17","author":"JL Kubinak","year":"2015","unstructured":"J.L. Kubinak, C. Petersen, W.Z. Stephens, R. Soto, E. Bake, R.M. O\u2019Connell et al. MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host Microbe 17(2), 153\u2013163 (2015). https:\/\/doi.org\/10.1016\/j.chom.2014.12.009","journal-title":"Cell Host Microbe"},{"issue":"1","key":"3828_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49462-w","volume":"9","author":"Q Zeng","year":"2019","unstructured":"Q. Zeng, D. Li, Y. He, Y. Li, Z. Yang, X. Zhao et al. Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities. Sci. Rep. 9(1), 13424 (2019). https:\/\/doi.org\/10.1038\/s41598-019-49462-w","journal-title":"Sci. Rep."},{"issue":"2","key":"3828_CR43","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1017\/S0954422410000247","volume":"23","author":"P Guilloteau","year":"2010","unstructured":"P. Guilloteau, L. Martin, V. Eeckhaut, R. Ducatelle, R. Zabielski, F. Van Immerseel, From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr. Res. Rev. 23(2), 366\u2013384 (2010). https:\/\/doi.org\/10.1017\/S0954422410000247","journal-title":"Nutr. Res. Rev."},{"issue":"D1","key":"3828_CR44","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkz764","volume":"48","author":"S Wu","year":"2020","unstructured":"S. Wu, C. Sun, Y. Li, T. Wang, L. Jia, S. Lai et al. GMrepo: a database of curated and consistently annotated human gut metagenomes. Nucleic Acids Res. 48(D1), D545\u2013D553 (2020). https:\/\/doi.org\/10.1093\/nar\/gkz764","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"3828_CR45","doi-asserted-by":"publisher","first-page":"e80702","DOI":"10.1371\/journal.pone.0080702","volume":"8","author":"M Tong","year":"2013","unstructured":"M. Tong, X. Li, L. Wegener Parfrey, B. Roth, A. Ippoliti, B. Wei et al. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One 8(11), e80702 (2013). https:\/\/doi.org\/10.1371\/journal.pone.0080702","journal-title":"PLoS One"},{"key":"3828_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.freeradbiomed.2020.04.013","volume":"156","author":"P Wang","year":"2020","unstructured":"P. Wang, J. Gao, W. Ke, J. Wang, D. Li, R. Liu et al. Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota. Free Radic. Biol. Med. 156, 83\u201398 (2020). https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.04.013","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"3828_CR47","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/molecules24061139","volume":"24","author":"Q Luo","year":"2019","unstructured":"Q. Luo, D. Cheng, C. Huang, Y. Li, C. Lao, Y. Xia et al. Improvement of Colonic Immune Function with Soy Isoflavones in High-Fat Diet-Induced Obese Rats. Molecules 24(6), 1139 (2019). https:\/\/doi.org\/10.3390\/molecules24061139","journal-title":"Molecules"},{"key":"3828_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep43412","volume":"7","author":"P Fan","year":"2017","unstructured":"P. Fan, P. Liu, P. Song, X. Chen, X. Ma, Moderate Dietary Protein Restriction Alters the Composition of Gut Microbiota and Improves Ileal Barrier Function in Adult Pig Model. Sci. Rep. 7, 43412 (2017). https:\/\/doi.org\/10.1038\/srep43412","journal-title":"Sci. Rep."},{"issue":"5","key":"3828_CR49","doi-asserted-by":"publisher","first-page":"e0205784","DOI":"10.1371\/journal.pone.0205784","volume":"14","author":"WY Yang","year":"2019","unstructured":"W.Y. Yang, Y. Lee, H. Lu, C.H. Chou, C. Wang, Analysis of Gut Microbiota and the Effect of Lauric Acid Against Necrotic Enteritis in Clostridium Perfringens and Eimeria Side-by-Side Challenge Model. PloS One 14(5), e0205784 (2019). https:\/\/doi.org\/10.1371\/journal.pone.0205784","journal-title":"PloS One"},{"issue":"7","key":"3828_CR50","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"H. Wu, E. Esteve, V. Tremaroli, M.T. Khan, R. Caesar, L. Manneras-Holm et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23(7), 850\u2013858 (2017). https:\/\/doi.org\/10.1038\/nm.4345","journal-title":"Nat. Med."},{"issue":"1","key":"3828_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1535370217743765","volume":"243","author":"Q Zhang","year":"2018","unstructured":"Q. Zhang, X. Xiao, J. Zheng, M. Li, M. Yu, F. Ping et al. Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats. Exp. Biol. Med. 243(1), 34\u201344 (2018). https:\/\/doi.org\/10.1177\/1535370217743765","journal-title":"Exp. Biol. Med."},{"issue":"11","key":"3828_CR52","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ijo.2013.20","volume":"37","author":"M Million","year":"2013","unstructured":"M. Million, E. Angelakis, M. Maraninchi, M. Henry, R. Giorgi, R. Valero et al. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int. J. Obes. 37(11), 1460\u20131466 (2013). https:\/\/doi.org\/10.1038\/ijo.2013.20","journal-title":"Int. J. Obes."},{"issue":"7","key":"3828_CR53","doi-asserted-by":"publisher","first-page":"e13649","DOI":"10.14814\/phy2.13649","volume":"6","author":"C Pedersen","year":"2018","unstructured":"C. Pedersen, U.Z. Ijaz, E. Gallagher, F. Horton, R.J. Ellis, E. Jaiyeola et al. Fecal Enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans. Physiol. Rep. 6(7), e13649 (2018). https:\/\/doi.org\/10.14814\/phy2.13649","journal-title":"Physiol. Rep."},{"key":"3828_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.722206","volume":"12","author":"Y Que","year":"2021","unstructured":"Y. Que, M. Cao, J. He, Q. Zhang, Q. Chen, C. Yan et al. Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential. Front. Immunol. 12, 722206 (2021). https:\/\/doi.org\/10.3389\/fimmu.2021.722206","journal-title":"Front. Immunol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03828-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03828-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03828-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T06:20:02Z","timestamp":1723270802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03828-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3828"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03828-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors affirm that all individual participants provided informed consent for the publication of the data. Additional informed consent was obtained from all individual participants for whom identifying information was included in this article. Written informed consent has been obtained from the patients to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of PUMCH (JS-2579\/202009.22). Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}